The third quarter will answer crucial questions about the near-term future of digital health. Will the upstart companies that enabled care and clinical trials to continue remotely during the pandemic have the same resonance and revenue growth as it recedes? Will they keep finding exit avenues via acquisitions, IPOs, or SPAC mergers?
Trending:
The health tech tracker for the third quarter: 11 pivotal industry events to watch